C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcγRI)

Immunology

Volumn 107, Issue 2, 2002, Pages 252-260

  Bodman Smith, Katherine B ^a   Melendez, Alirio J ^b   Campbell, Ian ^b   Harrison, Patrick T ^b   Allen, Janet M ^b   Raynes, John G ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM ION; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; PHOSPHOLIPASE D; PHOSPHORYLCHOLINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN COS7; CHIMERA; CONTROLLED STUDY; CROSS LINKING; ERYTHROCYTE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; NORMAL HUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; SHEEP; SIGNAL TRANSDUCTION;

ANIMALS; BINDING, COMPETITIVE; C-REACTIVE PROTEIN; CALCIUM; COS CELLS; ERYTHROCYTES; HUMANS; IMMUNOGLOBULIN G; PHAGOCYTOSIS; PHOSPHOLIPASE D; RECEPTORS, IGG; ROSETTE FORMATION; SHEEP; SIGNAL TRANSDUCTION; U937 CELLS;

EID: 0036413440     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01481.x     Document Type: Article

References (49)

1. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15:81-8.
2. Murphy TM, Baum LL, Beaman KD. Extrahepatic transcription of human C-reactive protein. J Exp Med 1991; 173:495-8.
3. Shrive AK, Cheetham GMT, Holden D et al. Three dimensional structure of human CRP. Nature, Struct Biol 1996; 3:346-54.
4. Kindmark CO. In vitro binding of human CRP by some pathogenic bacteria and zymosan. Clin Exp Immunol 1972; 11:283-9.
5. Culley FJ, Harris RA, Kaye PM, McAdam KPW, Raynes JG. CRP binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J Immunol 1996; 156:4691-6.
6. Kindmark CO. Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria. Clin Exp Immunol 1971; 8:941-8.
7. Richardson MD, Gray CA, Shankland GS. Opsonic effect of C-reactive protein on phagocytosis and intracellular killing of virulent and attenuated strains of Candida albicans by human neutrophils. FEMS, Microbiol Immunol 1991; 3:341-4.
8. Szalai AJ, Briles DE, Volanakis JE. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae. Infect Immun 1996; 64:4850-3.
9. Chudwin D, Artrip SG, Korenblit A, Schiffman G, Rao S. Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae. Infect Immun 1985; 50:213-17.
10. Muller H, Fehr J. Binding of C-reactive protein to human polymorphonuclear leukocytes: Evidence for association of binding sites with Fc receptors. J Immunol 1986; 136:2202-7.
11. Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW. CRP binds to FcγRI in transfected cos cells. J Immunol 1995; 155:2185-93.
12. Sondermann P, Huber R, Oosthuizen V, Jacob U. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 2000; 406:267-73.
13. Crowell RE, Du Clos TW, Montoya G, Heaphy E, Mold C. CRP receptors on the human monocytic cell line U-937. J Immunol 1991; 147:3445-51.
14. Stein MP, Edberg JC, Kimberley PP, Mangan EK, Bharadwaj D, Mold C, Du Clos TW. CRP binding to FcγRIIa on human monocytes and neutrophils is allele specific. J Clin Invest 2000; 105:369-76.
15. Du Clos TW, Mold C, Edberg JC, Kimberley RP. Reply to 'human CRP does not bind to FcγRIIa on phagocytic cells'. J Clin Invest 2001; 107:643.
16. Saeland E, van Royen A, Hendriksen K, Vile-Weekhout H, Rijkers GT, Sanders LAM, van der Winkel JGJ. C-reactive protein does not bind to FcγRIIa on pahgocytic cells. J Clin Invest 2001; 107:641-2.
17. Tebo JM, Mortensen RF. Characterisation and isolation of a CRP receptor from the human monocytic cell line U937. J Immunol 1990; 144:231-8.
18. Zhong W, Zen Q, Tebo J, Schlottmann K, Coggeshall M, Mortensen RF. Effect of human CRP on chemokine and chemotactic factor-induced chemotaxis and signalling. J Immunol 1998; 161:2533-40.
19. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991; 9:457-92.
20. Gosselin EJ, Wardell K, Gosselin DR, Alter N, Fisher JL, Guyre PM. Enhanced antigen presentation using FcγR (monocyte/macrophage) specific immunogens. J Immunol 1999; 149:3477-81.
21. Heijnen IAFM, van Vugt MJ, Fanger NA et al. Antigen targeting to myeloid specific human FcγRI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Invest 1996; 97:331-8.
22. Liu C, Goldstein J, Grazian RF, He J, O'Shea JK, Deo Y, Guyre GM. FcγRI targetted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonistic T cell epitopes. J Clin Invest 1996; 98:2001-7.
23. Heller T, Gesture JE, Schmidt RE, Los A, Bausch W, Kohl J. Fc receptor type I for IgG on macrophages and complement mediate the inflammatory response in immune complex peritonitis. J Immunol 1999; 162:5657-61.
24. Indik ZK, Park JG, Hunter S, Schreiber AD. Structure/function relationships of Fcg receptors in phagocytosis. Semin Immunol 1995; 7:45-54.
25. Allen JM, Seed B. Isolation and expression of functional high-affinity Fc receptor complementary DNAs. Science 1989; 243:378-81.
26. Davis W, Harrison PT, Hutchinson MJ, Allen JM. Two distinct regions of FcγRI initiate separate signalling pathways involved in endocytosis and phagocytosis. EMBO J 1995; 14:432-41.
27. Daëron M. Fc receptor biology. Annu Rev Immunol 1997; 15:203-34.
28. Mold C, Gresham D, Du Clos TW. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine FcγRs. J Immunol 2001; 166:1200-5.
29. Volanakis JE, Clements WL, Schrohenloher RE. CRP purification by affinity chromatography and physiochemical characterisation. J Immunol Methods 1978; 23:285-95.
30. Loveless RW, O'Sullivan G, Raynes JG, Yuen CT, Feizi T. Human SAP is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose, N-acetylgalactosamine and glucuronic acid. EMBO J 1992; 11:813-19.
31. Böyum A. Separation of lymphocytes, lymphocyte subgroups and monocytes: A review. Lymphology 1977; 10:71-6.
32. Seed B, Aruffo A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci USA 1987; 84:3365-9.
33. Küster H, Thompson H, Kinet JP. Characterization and expression of the gene for the human Fc receptor gamma subunit. Definition of a new gene family. J Biol Chem 1990; 265:6448-52.
34. Hutchinson MJ, Harrison PT, Floto RA, Allen JM. FcγR-mediated phagocytosis requires tyrosine kinase activity and is ligand independent. Eur J Immunol 1995; 25:481-7.
35. Sutterwala FS, Noel GJ, Clynes R, Mosser DM. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 1997; 185:1977-85.
36. Harrison PT, Campbell IW, Allen JM. Use of GPI-anchored proteins to study biomolecular interactions by surface plasmon resonance. FEBS Lett 1998; 422:301-6.
37. Harrison PT, Allen JM. High affinity IgG binding by FcγRI (CD64) is modulated by two distinct IgSF domains and the transmembrane domain of the receptor. Protein Engineering 1998; 11:225-32.
38. Melendez A, Floto RA, Gillooly DJ, Harnett MH, Allen JM. FcγRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilisation and vesicular trafficking. J Biol Chem 1998; 273:9393-402.
39. Dong A, Caughey WS, Du Clos TW. Effects of calcium, magnesium, and phosphorylcholine on secondary structures of human C-reactive protein and serum amyloid P component observed by infrared spectroscopy. J Biol Chem 1994; 269:6424-30.
40. Thompson D, Pepys MB, Wood SP. The physiological structure of human CRP and its complex with phosphocholine. Structure 1999; 7:169-77.
41. Sörensen IJ, Andersen O, Nielsen EH, Svehag SE. Native human serum amyloid P component is a single pentamer. Scand J Immunol 1995; 41:263-7.
42. Maxwell KF, Powell MS, Hulett MD, Barton PA, McKenzie IFC, Garrett TPJ, Hogarth PM. Crystal structure of the human leukocyte receptor FcγRIIa. Nature Structural Biol 1999; 6:437-42.
43. Kilpatrick JM, Volanakis JE. Opsonic properties of human CRP. Stimulation by PMA enables human neutrophils to phagocytose CRP coated cells. J Immunol 1985; 134:3364-70.
44. Kilpatrick JM, Gresham HD, Griffin FM Jr, Volanakis JE. Peripheral blood mononuclear leukocytes release a mediator (s) that induces phagocytosis of C-reactive protein-coated cells by polymorphonuclear leukocytes. J Leuk Biol 1987; 41:150-5.
45. Fjaertoft G, Hakansson L, Ewald U, Foucard T, Venge P. Neutrophils from term and preterm newborn infants express the high affinity FcγRI (CD64) during bacterial infections. Pediatr Res 1999; 45:871-6.
46. Romero IR, Morris C, Rodriguez M, Du Clos TW, Mold C. Inflammatory potential of C-reactive protein complexes compared to immune complexes. Clin Immunol Immunopathol 1998; 87:155-62.
47. Heuertz RM, Trocomi SM, Ezekiel UR, Webster RO. CRP inhibits chemotactic peptide induced p38 MAP kinase activity and human neutrophil movement. J Biol Chem 1999; 274:17968-74.
48. Sutterwala FS, Noel GJ, Salgame P, Mosser DA. Reversal of proinflammatory responses by ligating the macrophage FcγRI. J Exp Med 1998; 188:217-22.
49. van Vugt M, Kleijmeer MJ, Keler T, Zeelenberg I, van Dijk MA, Leussen JHW, Geuze HJ, van der Winkel JGJ. The FcγRIa (CD64) ligand binding chain triggers MHCII antigen presentation independently of its associated FcR γ chain. Blood 1999; 94:808-17.